S0569B0631A01582 DMS:JMT 06/03/19 #90 A01582
AMENDMENTS TO SENATE BILL NO. 569
Sponsor: SENATOR BROOKS
Printer's No. 631
Amend Bill, page 2, line 17, by inserting after "prescriber,"
transdermal
Amend Bill, page 2, line 19, by striking out "seven-day
supply of" and inserting
single unit of five (5) patches of transdermal
Amend Bill, page 2, by inserting between lines 24 and 25
(c) A pharmacist who receives a prescription for transdermal
fentanyl shall not be required to verify that the documentation
requirements for prescribers under subsection (b) have been met.
The pharmacist shall comply with 21 CFR 1306.04 (relating to
purpose of issue of prescription).
Amend Bill, page 2, line 25, by striking out "(c)" and
inserting
(d)
Amend Bill, page 3, line 2, by striking out "(d)" and
inserting
(e)
Amend Bill, page 3, line 4, by striking out "(e)" and
inserting
(f)
2019/90DMS/SB0569A01582 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
See A01582 in
the context
of SB0569